Jin Joo Park Selected Research

Jin Joo Park Research Topics

Disease

31	Heart Failure 03/2024 - 02/2014
13	Myocardial Infarction 08/2021 - 12/2010
8	Thrombosis (Thrombus) 01/2021 - 01/2012
8	Death (Near-Death Experience) 01/2021 - 01/2012
4	Chronic Renal Insufficiency 02/2021 - 01/2011
4	Acute Coronary Syndrome 01/2021 - 09/2013
3	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 11/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 02/2012
3	Pathologic Constriction (Stenosis) 10/2017 - 09/2010
2	Anemia 06/2023 - 09/2016
2	Stroke (Strokes) 01/2023 - 09/2013
2	Ischemia 01/2023 - 10/2017
2	Ischemic Stroke 08/2021 - 09/2012
2	Prediabetic State (Prediabetes) 02/2021 - 11/2018
2	Hypertension (High Blood Pressure) 01/2021 - 06/2018
2	Inflammation (Inflammations) 01/2021 - 03/2019
2	Fibrosis (Cirrhosis) 07/2020 - 03/2019
2	Hyperplasia 07/2019 - 07/2015
2	Diabetes Mellitus 11/2018 - 02/2012
2	Hyponatremia 12/2017 - 07/2015
2	ST Elevation Myocardial Infarction 12/2016 - 03/2013
2	Atherosclerosis 05/2016 - 03/2013
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2016 - 09/2013
1	Type 2 Diabetes Mellitus (MODY) 12/2023
1	Heart Valve Diseases (Valvular Heart Disease) 06/2023
1	Cardiac Arrhythmias (Arrythmia) 01/2023
1	Atrial Fibrillation 01/2023
1	Unstable Angina 08/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Tachycardia (Tachyarrhythmias) 01/2021
1	Necrosis 07/2020
1	Carotid Artery Diseases 07/2020
1	Sclerosis 07/2020
1	Peripheral Arterial Disease 07/2020
1	Hyperkalemia 10/2019
1	Hypotension (Low Blood Pressure) 10/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2017

Drug/Important Bio-Agent (IBA)

6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 12/2016
5	Clopidogrel (Plavix)FDA Link 06/2023 - 02/2012
4	Natriuretic PeptidesIBA 10/2022 - 02/2014
4	pro-brain natriuretic peptide (1-76)IBA 09/2017 - 02/2014
3	Carvedilol (Coreg)FDA LinkGeneric 01/2023 - 02/2018
3	C-Reactive ProteinIBA 01/2022 - 02/2012
3	SodiumIBA 12/2017 - 07/2015
2	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2022 - 10/2019
2	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 11/2018
2	CreatinineIBA 01/2021 - 01/2018
2	DiureticsIBA 01/2021 - 01/2018
2	CholesterolIBA 07/2020 - 09/2010
2	LipidsIBA 07/2020 - 11/2018
2	omega-Chloroacetophenone (Mace)IBA 10/2017 - 04/2015
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2017 - 12/2015
2	CalciumIBA 12/2016 - 09/2010
2	Cilostazol (Pletal)FDA LinkGeneric 01/2016 - 09/2013
2	Adenosine (Adenocard)FDA LinkGeneric 05/2015 - 02/2013
2	Biomarkers (Surrogate Marker)IBA 08/2014 - 03/2013
1	dapagliflozinIBA 02/2024
1	empagliflozinIBA 01/2024
1	Adenosine Monophosphate (AMP)IBA 01/2024
1	Metformin (Glucophage)FDA LinkGeneric 12/2023
1	BESIBA 01/2023
1	Vitamin K FDA Link 01/2023
1	RivaroxabanIBA 01/2023
1	AnticoagulantsIBA 01/2023
1	vericiguatIBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 02/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	PolymersIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 07/2020
1	oxidized low density lipoproteinIBA 07/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2020
1	oil red OIBA 07/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020
1	Neprilysin (Neutral Endopeptidase)IBA 10/2019
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2019
1	MetalsIBA 07/2019
1	fimasartanIBA 03/2019
1	Angiotensin Receptor AntagonistsIBA 03/2019
1	Tirofiban (Aggrastat)FDA Link 10/2018
1	Chlorthalidone (Chlortalidone)FDA LinkGeneric 06/2018
1	Telmisartan (Micardis)FDA Link 06/2018
1	Amlodipine (Norvasc)FDA LinkGeneric 06/2018
1	Mineralocorticoid Receptor AntagonistsIBA 01/2018

Therapy/Procedure

10	Stents 01/2023 - 01/2011
8	Therapeutics 01/2020 - 01/2012
5	Drug-Eluting Stents 01/2023 - 01/2011
3	Patient Readmission 01/2022 - 09/2016
3	Percutaneous Coronary Intervention 10/2018 - 03/2013
2	Heart Transplantation (Grafting, Heart) 03/2024 - 01/2016
2	Drug Therapy (Chemotherapy) 10/2019 - 12/2010
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2016 - 12/2010
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2020
1	Endarterectomy (Thromboendarterectomy) 07/2020
1	Critical Care (Surgical Intensive Care) 06/2018